Mereo Biopharma Group PLC (MREO) — 10-Q Filings

10-Q Filings (6)

• Mereo Narrows Q3 Loss Amid Rising R&D, Cash Dips to $48.7M — Nov 10, 2025 Risk: high
  Mereo BioPharma Group plc reported a net loss of $7.024 million for the three months ended September 30, 2025, a significant improvement from the $15.001 millio
• Mereo Narrows Q2 Loss Amid Pipeline Focus, Strategic Partnerships — Aug 12, 2025 Risk: high
  Mereo BioPharma Group plc reported a net loss of $10.2 million for the three months ended June 30, 2025, a significant improvement from the $15.8 million net lo
• Mereo BioPharma Files Q1 2025 10-Q Report — May 13, 2025 Risk: medium
  Mereo BioPharma Group plc filed its 10-Q for the period ending March 31, 2025. The company reported on its financial performance and business operations. Key fi
• Mereo BioPharma Files Q3 2024 10-Q — Nov 12, 2024 Risk: medium
  Mereo BioPharma Group plc filed its 10-Q for the period ending September 30, 2024. The company reported on its financial performance and operations, including d
• Mereo BioPharma Files 10-Q: Convertible Debt & Novartis Loan Update — Aug 13, 2024 Risk: medium
  Mereo BioPharma Group plc filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates. Key financial in
• Mereo BioPharma Group plc Files 10-Q for Period Ending March 31, 2024 — May 15, 2024 Risk: low
  Mereo BioPharma Group plc (MREO) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. Mereo BioPharma Group plc filed a 10-Q report for the period endi

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX